| CAT No: | CL-PLKT-NO-01 |
| CAS No: | NA |
| Mol.F: | C27H22N6O5 |
| Mol.Wt.: | 510.5 |
| Chemical Name: | N-(2-(1-nitroso-1H-tetrazol-5-yl)-4-oxo-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide |
| Inventory Status: | Custom synthesis |
This impurity is related to N-Nitroso Pranlukast Impurity 1 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
N-Nitroso Pranlukast Impurity 1 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:N-(2-(1-nitroso-1H-tetrazol-5-yl)-4-oxo-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Pranlukast Molecular Formula: C27H22N6O5
Molecular Weight: 510.5
Storage: Store in a cool, dry place.
| Product Name: | N-Nitroso Pranlukast Impurity 1 |
| CAS No: | |
| Mol.F.: | C27H22N6O5 |
| Mol.Wt.: | 510.5 |
Cat. No: CL-PLKT-01
CAS No: 103177-37-3
Mol. F: C27H23N5O4
Mol. Wt: 481.5
Inv. Status: Custom Synthesis
Cat. No: CL-PLKT-02
CAS No: 110683-23-3
Mol. F: C10H7N5O2 : HCl
Mol. Wt: 229.2 : 36.5
Inv. Status: Custom Synthesis
Cat. No: CL-PLKT-03
CAS No: 136450-05-0
Mol. F: C18H20O3
Mol. Wt: 284.4
Inv. Status: Custom Synthesis
Cat. No: CL-PLKT-04
CAS No: 30131-16-9
Mol. F: C17H18O3
Mol. Wt: 270.3
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: